Aptahem AB (publ)
APTA
Rank in Stocks
#33398
Aptahem AB (publ) is a clinical-stage biotechnology company dedicated to... Aptahem AB (publ) is a clinical-stage biotechnology company dedicated to creating aptamer-based pharmaceuticals aimed at treating acute, life-threatening medical conditions. Its flagship drug candidate, Apta-1, is currently in preclinical development, designed to reduce the mortality rate in sepsis patients by combating organ and tissue damage. The company has established partnerships with several academic institutions, notably through a consortium comprising Örebro University, Seattle Children's Research Institute, and University Health Network. Founded in 2014, Aptahem AB (publ) operates from its headquarters in Malmö, Sweden.
Share Price
$0.02219701
Last synced: 2026-11-05
Market Cap
$575.64K
Change (1 day)
6.90%
Change (1 year)
-80.00%
Country
Stock data: Financial Modeling Prep·Updated ·Not investment advice·How we calculate this
Trade Aptahem AB (publ) (APTA)
Category
Healthcare
Operating Margin for Aptahem AB (publ) (APTA)
Operating Margin as of November 2026 TTM: -1,706.43%
According to Aptahem AB (publ)'s latest financial reports, its current operating margin (TTM) is -1,706.43%. At the end of 2025 the company had an operating margin of 0.00%.
Operating Margin history for Aptahem AB (publ) from 2016 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | -1,706.43% | 0.00% |
| 2025 | 0.00% | -100.00% |
| 2024 | -216.98% | -43.51% |
| 2023 | -384.12% | 44.95% |
| 2022 | -265.00% | 0.00% |
| 2021 | 0.00% | 0.00% |
| 2020 | 0.00% | 0.00% |
| 2019 | 0.00% | -100.00% |
| 2018 | -708,735.03% | 281.77% |
| 2017 | -185,646.50% | 3,111.08% |
| 2016 | -5,781.44% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 38.59% | -100.02% |
US
|
|
| -149.01% | -99.91% |
US
|
|
| 25.57% | -100.01% |
AU
|
|
| 31.23% | -100.02% |
BE
|
|
| 29.35% | -100.02% |
NL
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about Aptahem AB (publ)'s operating margin
What is Aptahem AB (publ)'s operating margin?
Aptahem AB (publ)'s operating margin is -1,706.43%, as of Nov 2026.
What was Aptahem AB (publ)'s operating margin in 2025?
In 2025, Aptahem AB (publ)'s operating margin was 0.00%, compared with -216.98% in 2024.
How has Aptahem AB (publ)'s operating margin changed since 2020?
From 2020 to 2025, Aptahem AB (publ)'s operating margin was highest in 2025 (0.00%) and lowest in 2023 (-384.12%).
How does Aptahem AB (publ)'s operating margin compare with similar companies?
Aptahem AB (publ)'s operating margin (-1,706.43%) is lower than that of all 5 similar companies listed above. The highest among them is Vertex Pharmaceuticals Incorporated, with 38.59%.